FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine and deals with liquid pharmaceutical composition for treating disorder in which TNF-alpha activity is harmful, with said composition having pH from approximately 5.0 to 6.4 and including approximately 35-55 mg/ml of polyol and approximately 40-200 mg/ml of human antibody against TNF-alpha, where composition does not contain NaCl filler. Group of inventions also deals with method of treating disorder, associated with harmful activity of TNF-alpha, in subject, which includes introduction of said composition to subject.
EFFECT: group of inventions provides preparations with high concentration of antibody, possessing prolonged stability and characteristics useful for subcutaneous introduction.
49 cl, 11 ex, 26 dwg, 27 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| IMPROVED HIGH-CONCENTRATED LIQUID PREPARATIONS OF ANTIBODIES AGAINST TNF-ALPHA | 2011 |
|
RU2639386C2 |
| METHODS AND COMPOSITIONS FOR DIAGNOSTICS OF ANKYLOSING SPONDYLITIS WITH APPLICATION OF BIO-MARKERS | 2006 |
|
RU2438704C2 |
| ANTIBODIES AGAINST TNF-α AND USE THEREOF | 2010 |
|
RU2595379C2 |
| METHODS FOR IDENTIFYING ANTIBODIES WITH REDUCED IMMUNOGENICITY | 2013 |
|
RU2648141C2 |
| ANTIBODY PURIFICATION | 2007 |
|
RU2466740C2 |
| LIQUID PHARMACEUTICAL COMPOSITION | 2015 |
|
RU2719431C2 |
| COMPOSITIONS OF ANTIBODIES | 2005 |
|
RU2426554C2 |
| METHODS OF TREATING NON-RADIOGRAPHIC AXIAL SPONDYLARTHRITIS BY USING INTERLEUKIN-17 (IL-17) ANTAGONISTS | 2016 |
|
RU2728710C2 |
| LIBRARY OF CONCENTRATION-DEPENDENT ION BINDING MOLECULES | 2012 |
|
RU2812861C1 |
| FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES | 2013 |
|
RU2683861C2 |
